Joint drug program releases findings

Major League Baseball and the Major League Players Association put out their joint 2012-2013 Major League Baseball drug report.

Here’s the transcript:

The report covers from the 2012 offseason to the end of the 2013 Major League Baseball post-season. The report is specific to Players who compose forty-man rosters for Major League Baseball Clubs.

1) The total number of drug tests that were conducted for the presence of Performance Enhancing Substances and/or Stimulants during the time listed above was 5,391 tests. The number of urine samples that were collected and analyzed for the presence of Performance Enhancing Substances and/or Stimulants was 4,022. The number of blood samples that were collected and analyzed for the presence of human growth hormone was 1,369.

Advertisement

2) Eight tests were reported by the testing laboratory for having an adverse analytical finding that resulted in discipline. All were for Stimulants. The substances reported were as follows: Adderall: 7; Methylhexaneamine: 1

3) 13 non-analytical positives resulted in discipline.

4) 122 Therapeutic Use Exemptions were granted. The diagnoses were as follows: Attention Deficit Disorder: 119; Hypogonadism: 3

Respectfully submitted,
Jeffrey M. Anderson, MD
Independent Program Administrator
Major League Baseball’s Joint Drug Prevention and Treatment Program

Loading Comments...